Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Cremoni

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|May 23, 2022
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Journal of Clinical Immunology|August 22, 2023
Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern FranceDaisy Graça, Vesna Brglez, Jonathan Allouche, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2023
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous NephropathyMaxime Teisseyre, Vesna Brglez, Marion Cremoni, et al.
Kidney International Reports|July 11, 2022
Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety DatabaseAlexandre O Gérard, Diane Merino, Audrey Laurain, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2022
Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular diseaseMaxime Teisseyre, Daisy Graça, Daniel Re, et al.
Frontiers in Immunology|April 17, 2023
Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responsesMatthieu Buscot, Marion Cremoni, Daisy Graça, et al.
Frontiers in Immunology|December 16, 2020
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and RelapsesMarion Cremoni, Vesna Brglez, Sandra Perez, et al.
Frontiers in Medicine|April 11, 2022
Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care IntensityDenis Doyen, Lucas Morand, Mathieu Jozwiak, et al.
Frontiers in Medicine|February 15, 2021
Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort StudyMarion Cremoni, Caroline Ruetsch, Kévin Zorzi, et al.
NPJ Vaccines|May 4, 2026
Immunogenicity of PCV13 during Hospitalization soon after infection resolution: Vaccis studyJulie Mérindol, Irit Touitou, Coralie Cruzel, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|May 23, 2022
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Journal of Clinical Immunology|August 22, 2023
Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern FranceDaisy Graça, Vesna Brglez, Jonathan Allouche, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2023
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous NephropathyMaxime Teisseyre, Vesna Brglez, Marion Cremoni, et al.
Kidney International Reports|July 11, 2022
Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety DatabaseAlexandre O Gérard, Diane Merino, Audrey Laurain, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2022
Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular diseaseMaxime Teisseyre, Daisy Graça, Daniel Re, et al.
Frontiers in Immunology|April 17, 2023
Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responsesMatthieu Buscot, Marion Cremoni, Daisy Graça, et al.
Frontiers in Immunology|December 16, 2020
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and RelapsesMarion Cremoni, Vesna Brglez, Sandra Perez, et al.
Frontiers in Medicine|April 11, 2022
Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care IntensityDenis Doyen, Lucas Morand, Mathieu Jozwiak, et al.
Frontiers in Medicine|February 15, 2021
Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort StudyMarion Cremoni, Caroline Ruetsch, Kévin Zorzi, et al.
NPJ Vaccines|May 4, 2026
Immunogenicity of PCV13 during Hospitalization soon after infection resolution: Vaccis studyJulie Mérindol, Irit Touitou, Coralie Cruzel, et al.
Pageof 4